Literature DB >> 12481794

The therapeutic misconception, beneficence, and respect.

E Fried1.   

Abstract

In order to provide benefits to society, human medical trials must place subjects at risk of harm. This activity is thought to be justified in part by the consent of the subjects involved. But, studies have shown that most such consents are based on a therapeutic misconception (TM); the false belief of subjects that their researchers will act as their personal physicians (seeking their benefit and protecting them from harm), rather than placing them at risk of harm for the good of others. Toleration by researchers of the TM in their subjects is a form of "informational manipulation" that renders consent procedures disrespectful to subject autonomy. Consent obtained from subjects who labor under a TM is neither voluntary nor informed; as long as they have not been disabused of the TM, the action they take in enrolling in a trial is not the one they intend nor is it autonomously chosen. Changes in consent procedures should be adopted to ensure that all subjects are aware inter alia that (a) the health interests of future patients (as well as the researchers' and their sponsors' financial interests) may be more important to researchers than the interest of a subject in his or her health, and (b) normal subjects neither understand nor believe this when told. Close attention to the response of prospective subjects to this information should allow for the exclusion of all but the truly altruistic. However, the result of conscientious implementation of such policies would likely be that human medical research could no longer be conducted on more than a minimal level.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research

Mesh:

Year:  2001        PMID: 12481794     DOI: 10.1080/08989620108573984

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  2 in total

1.  Subjects' expectations in neuroimaging research.

Authors:  Matthew P Kirschen; Agnieszka Jaworska; Judy Illes
Journal:  J Magn Reson Imaging       Date:  2006-02       Impact factor: 4.813

2.  Incidental findings of therapeutic misconception in biobank-based research.

Authors:  Colin M E Halverson; Lainie Friedman Ross
Journal:  Genet Med       Date:  2012-01-26       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.